(1) Maintenance treatment of asthma as prophylactic therapy.
(2) For asthma patients who require systemic corticosteroid administration, where adding QVAR may reduce or eliminate the need for the systemic corticosteroids.
(1) For the treatment or prevention of bronchospasm in patients with reversible obstructive airway disease.
(2) For the prevention of exercise-induced bronchospasm.
QNASL (beclomethasone dipropionate)
Nasal Aerosol is indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older.